BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11264591)

  • 1. Crystallization and preliminary X-ray crystallographic analysis of the human type 3 3 alpha-hydroxysteroid dehydrogenase at 1.8 A resolution.
    Zhu DW; Cantin L; Nahoum V; Rehse P; Luu-The V; Labrie F; Breton R; Lin SX
    Acta Crystallogr D Biol Crystallogr; 2001 Apr; 57(Pt 4):589-91. PubMed ID: 11264591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cloning of human type 3 3 alpha-hydroxysteroid dehydrogenase that differs from 20 alpha-hydroxysteroid dehydrogenase by seven amino acids.
    Dufort I; Soucy P; Labrie F; Luu-The V
    Biochem Biophys Res Commun; 1996 Nov; 228(2):474-9. PubMed ID: 8920937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones.
    Penning TM; Burczynski ME; Jez JM; Hung CF; Lin HK; Ma H; Moore M; Palackal N; Ratnam K
    Biochem J; 2000 Oct; 351(Pt 1):67-77. PubMed ID: 10998348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased ratio of 5 alpha-reductase: 3 alpha (beta)-hydroxysteroid dehydrogenase activities in the hyperplastic human prostate.
    Bruchovsky N; Lieskovsky G
    J Endocrinol; 1979 Mar; 80(3):289-301. PubMed ID: 86594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men.
    Blouin K; Richard C; Brochu G; Hould FS; Lebel S; Marceau S; Biron S; Luu-The V; Tchernof A
    J Endocrinol; 2006 Dec; 191(3):637-49. PubMed ID: 17170221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and characterization of recombinant type 2 3 alpha-hydroxysteroid dehydrogenase (HSD) from human prostate: demonstration of bifunctional 3 alpha/17 beta-HSD activity and cellular distribution.
    Lin HK; Jez JM; Schlegel BP; Peehl DM; Pachter JA; Penning TM
    Mol Endocrinol; 1997 Dec; 11(13):1971-84. PubMed ID: 9415401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystallization and preliminary X-ray analysis of the complex of NADH and 3alpha-hydroxysteroid dehydrogenase from Pseudomonas sp. B-0831.
    Kataoka S; Nakamura S; Ohkubo T; Ueda S; Uchiyama S; Kobayashi Y; Oda M
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Jun; 62(Pt 6):569-71. PubMed ID: 16754984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma.
    Fung KM; Samara EN; Wong C; Metwalli A; Krlin R; Bane B; Liu CZ; Yang JT; Pitha JV; Culkin DJ; Kropp BP; Penning TM; Lin HK
    Endocr Relat Cancer; 2006 Mar; 13(1):169-80. PubMed ID: 16601286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid recognition and regulation of hormone action: crystal structure of testosterone and NADP+ bound to 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase.
    Bennett MJ; Albert RH; Jez JM; Ma H; Penning TM; Lewis M
    Structure; 1997 Jun; 5(6):799-812. PubMed ID: 9261071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells.
    Rizner TL; Lin HK; Peehl DM; Steckelbroeck S; Bauman DR; Penning TM
    Endocrinology; 2003 Jul; 144(7):2922-32. PubMed ID: 12810547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human types 1 and 3 3 alpha-hydroxysteroid dehydrogenases: differential lability and tissue distribution.
    Dufort I; Labrie F; Luu-The V
    J Clin Endocrinol Metab; 2001 Feb; 86(2):841-6. PubMed ID: 11158055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of the human 3alpha-hydroxysteroid dehydrogenase type 3 in complex with testosterone and NADP at 1.25-A resolution.
    Nahoum V; Gangloff A; Legrand P; Zhu DW; Cantin L; Zhorov BS; Luu-The V; Labrie F; Breton R; Lin SX
    J Biol Chem; 2001 Nov; 276(45):42091-8. PubMed ID: 11514561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen inactivation in human lung fibroblasts: variations in levels of 17 beta-hydroxysteroid dehydrogenase type 2 and 5 alpha-reductase activity compatible with androgen inactivation.
    Provost PR; Blomquist CH; Drolet R; Flamand N; Tremblay Y
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3883-92. PubMed ID: 12161528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering steroid 5 beta-reductase activity into rat liver 3 alpha-hydroxysteroid dehydrogenase.
    Jez JM; Penning TM
    Biochemistry; 1998 Jul; 37(27):9695-703. PubMed ID: 9657682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase complexed with NADP+.
    Bennett MJ; Schlegel BP; Jez JM; Penning TM; Lewis M
    Biochemistry; 1996 Aug; 35(33):10702-11. PubMed ID: 8718859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammalian 3 alpha-hydroxysteroid dehydrogenases.
    Penning TM; Pawlowski JE; Schlegel BP; Jez JM; Lin HK; Hoog SS; Bennett MJ; Lewis M
    Steroids; 1996 Sep; 61(9):508-23. PubMed ID: 8883217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification, crystallization and preliminary X-ray diffraction results of human 17beta-hydroxysteroid dehydrogenase type 5.
    Zhou M; Qiu W; Chang HJ; Gangloff A; Lin SX
    Acta Crystallogr D Biol Crystallogr; 2002 Jun; 58(Pt 6 Pt 2):1048-50. PubMed ID: 12037313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human 3α-hydroxysteroid dehydrogenase type 3: structural clues of 5α-DHT reverse binding and enzyme down-regulation decreasing MCF7 cell growth.
    Zhang B; Hu XJ; Wang XQ; Thériault JF; Zhu DW; Shang P; Labrie F; Lin SX
    Biochem J; 2016 Apr; 473(8):1037-46. PubMed ID: 26929402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion of mammalian 3alpha-hydroxysteroid dehydrogenase to 20alpha-hydroxysteroid dehydrogenase using loop chimeras: changing specificity from androgens to progestins.
    Ma H; Penning TM
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11161-6. PubMed ID: 10500147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the major oxidative 3alpha-hydroxysteroid dehydrogenase in human prostate that converts 5alpha-androstane-3alpha,17beta-diol to 5alpha-dihydrotestosterone: a potential therapeutic target for androgen-dependent disease.
    Bauman DR; Steckelbroeck S; Williams MV; Peehl DM; Penning TM
    Mol Endocrinol; 2006 Feb; 20(2):444-58. PubMed ID: 16179381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.